Nestin involvement in tissue injury and cancer - a potential tumor marker?
- 28 August 2014
- journal article
- review article
- Published by Springer Nature in Cellular Oncology
- Vol. 37 (5) , 305-315
Abstract
In eukaryotic cells, the cytoskeleton contains three major filamentous components: actin microfilaments, microtubules and intermediate filaments. Nestin represents one of the class VI intermediate filament proteins. Clinical and molecular analyses have revealed substantial information regarding the presence of Nestin in cells with progenitor or stem cell properties. During tissue injury Nestin is expressed in cells with progenitor cell-like properties. These cells may serve as a tissue reserve and, as such, may contribute to tissue repair. Based on currently available data, Nestin also appears to be implicated in two oncogenic processes. First, Nestin has been found to be expressed in cancer stem-like cells and poorly differentiated cancer cells and, as such, Nestin is thought to contribute to the aggressive behavior of these cells. Second, Nestin has been found to be involved in tumor angiogenesis through an interaction of cancer cells and blood vessel endothelial cells and, as such, Nestin is thought to facilitate tumor growth. We conclude that Nestin may serve as a promising tumor marker and as a potential therapeutic target amenable to tumor suppression and angiogenesis inhibition.Keywords
This publication has 97 references indexed in Scilit:
- DLK1-DIO3 Genomic Imprinted MicroRNA Cluster at 14q32.2 Defines a Stemlike Subtype of Hepatocellular Carcinoma Associated with Poor SurvivalJournal of Biological Chemistry, 2011
- Nestin in gastrointestinal and other cancers: Effects on cells and tumor angiogenesisWorld Journal of Gastroenterology, 2011
- The Neural Stem/Progenitor Cell Marker Nestin Is Expressed in Proliferative Endothelial Cells, but Not in Mature VasculatureJournal of Histochemistry & Cytochemistry, 2010
- Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1Molecular and Cellular Biochemistry, 2010
- Nestin expression correlates with nerve and retroperitoneal tissue invasion in pancreatic cancerHuman Pathology, 2009
- Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patientsJournal of Experimental & Clinical Cancer Research, 2008
- The prognostic value of nestin expression in newly diagnosed glioblastoma: Report from the Radiation Therapy Oncology GroupRadiation Oncology, 2008
- Targeting Cancer Stem Cells through L1CAM Suppresses Glioma GrowthCancer Research, 2008
- Tumour stem cells and drug resistanceNature Reviews Cancer, 2005
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences of the United States of America, 2003